Clinical trials for advancing innovative interventions for neurodegenerative diseases[E8]

Dal bando

Call: Cluster 1 - Health (Two stage - 2027). Type of action: HORIZON Research and Innovation Actions. Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes: The scientific and clinical communities make effective use of state-of-the-art knowledge, data, technologies, tools, methods, best practices, and trainings to underpin and complement the development of innovative interventions aimed at more effective treatments for neurodegenerative diseases. The scientific and clinical communities benefit from the exchange of data, knowledge and best practices, thereby strengthening their collaboration in the EU, the Associated Countries and beyond. The scientific and clinical communities make wide use of relevant databases and/or integrate them with existing infrastructures for storage and sharing of collected data according to FAIR [1] principles, thereby encouraging further use of the data. Policymakers, funders, scientific and clinical communities, patient organisations, regulators, and other relevant bodies are informed of the research advances made and the requirements for a widespread implementation of the innovative therapeutic interventions and complementary approaches. Patients and caregivers are constructively engaged with the research, ensuring that their needs are catered for…[E3]

I dettagli del bando sono mostrati come li ha pubblicati la fonte. I fatti e i requisiti che estraiamo sono scritti in inglese.

• Aperto aUniversities and research. Etichettato da SLETOR in base alle parole del bando.
• CondizioneEU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.[E4]

• RischioThis is a grant, not a contract. Grants usually need a proposal against the funder's criteria, may need partners and often need co-funding.[E5]
• SconosciutoWe read the funder's listing, not the full guidance or application forms.

1. Aperto alle offerte · 29 ott 2026, 07:41 UTC

   The funder published the call with a future closing date.

   Modificato: status, notice type, published at (record di origine Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage))

2. Visto per la prima volta · 28 ott 2026, 21:22 UTC

   The funder announced the call. Applications have not opened yet.

   Record di origine: Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage)

Ogni dato di questa pagina viene dal bando dell'ente. Ogni voce mostra il record e il campo da cui è stato letto.

1. E1

   The funder is European Commission.

   Da Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage), campo /metadata/type/0, letto 29 ott 2026, 07:41 UTC · fonte ↗ (si apre in una nuova scheda)

2. E2

   Proposals must be submitted by 17 Feb 2027, 01:00 Central European time (UTC+1).

   “2027-02-17T00:00:00.000+0000”

   Da Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage), campo /metadata/deadlineDate/0, letto 29 ott 2026, 07:41 UTC · fonte ↗ (si apre in una nuova scheda)

3. E3

   The buyer describes the requirement in the notice.

   “Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed…”

   Da Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage), campo /metadata/descriptionByte/0, letto 29 ott 2026, 07:41 UTC · fonte ↗ (si apre in una nuova scheda)

4. E4

   EU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.

   “EU call topic”

   Da Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage), campo /metadata/type/0, letto 29 ott 2026, 07:41 UTC · fonte ↗ (si apre in una nuova scheda)

5. E5

   This is an EU call for proposals.

   “31094502”

   Da Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage), campo /metadata/status/0, letto 29 ott 2026, 07:41 UTC · fonte ↗ (si apre in una nuova scheda)

6. E6

   Applications open on 29 Oct 2026.

   “2026-10-29T00:00:00.000+0000”

   Da Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage), campo /metadata/startDate/0, letto 29 ott 2026, 07:41 UTC · fonte ↗ (si apre in una nuova scheda)

7. E7

   The Funding & Tenders Portal gives the status as open for submission.

   Da Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage), campo /metadata/status/0, letto 29 ott 2026, 07:41 UTC · fonte ↗ (si apre in una nuova scheda)

8. E8

   The notice is titled "Clinical trials for advancing innovative interventions for neurodegenerative diseases".

   Da Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage), campo /metadata/title/0, letto 29 ott 2026, 07:41 UTC · fonte ↗ (si apre in una nuova scheda)

9. E9

   The EU contribution per grant is up to EUR 10,000,000 (from EUR 5,000,000).

   Da Clinical trials for advancing innovative interventions for neurodegenerative di… (ID HORIZON-HLTH-2027-02-DISEASE-14-two-stage), campo /metadata/budgetOverview/0, letto 29 ott 2026, 07:41 UTC · fonte ↗ (si apre in una nuova scheda)

Source: EU Funding & Tenders Portal, © European Union, CC BY 4.0. SLETOR shortened and reformatted the text. Licenza dei dati: Creative Commons Attribution 4.0 (European Commission) ↗ (si apre in una nuova scheda). I recapiti personali presenti nei bandi non vengono conservati né mostrati.